Ono Pharmaceutical Co Ltd
Ono Pharmaceutical Waste Data Preview
In 2023, Ono Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
Insights into Ono Pharmaceutical's Waste Treatment Practices
In 2023, Ono Pharmaceutical generated a total of 570 metric tonnes of waste.
Of this amount, 99.98% of Ono Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 0.02% was disposed of through landfilling, incineration, or combustion.
Ono Pharmaceutical's Waste Recovery Rate
How much of Ono Pharmaceutical's waste is recycled or recovered?
In 2023, Ono Pharmaceutical reported a total waste generation of 570 metric tonnes, of which 99.98% was recovered through recycling, reuse, or composting. This high recovery rate suggests that Ono Pharmaceutical has implemented strong circular economy practices and actively prioritizes sustainable waste management.
Has Ono Pharmaceutical reduced its environmental waste footprint over time?
Since 2021, Ono Pharmaceutical's total waste generation increased by 18.91%, including a 15.6% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.
Over the same period, Ono Pharmaceutical's waste recovery rate remained stable both in the long term and in 2023, suggesting limited progress, or consistent recovery performance, without major shifts in strategy.
Overall, Ono Pharmaceutical's waste generation is rising, yet its recovery rates have remained stagnant. This suggests that the company’s operational growth is not being matched by parallel improvements in its waste treatment practices, potentially increasing its environmental footprint.
Ono Pharmaceutical’s Waste Recovery vs. Disposal Over Time
- Total Waste Disposed
- Total Waste Recovered
Insights into Ono Pharmaceutical’s Generation of Hazardous and Non-Hazardous Waste
In 2023, Ono Pharmaceutical generated a total of 570 metric tonnes of waste.
Of this amount, 25.54% of Ono Pharmaceutical's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 74.46% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Ono Pharmaceutical’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How Ono Pharmaceutical reduced the environmental impact of its waste?
Since 2021, Ono Pharmaceutical's total waste generation increased by 18.91%, including a 15.6% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, Ono Pharmaceutical reduced the hazardousness of its waste by 28.15%, with a further 11.68% decline in 2023, suggesting a sustained and meaningful shift toward safer waste profiles and lower environmental impact.
Overall, Ono Pharmaceutical is generating more waste but has significantly reduced the share of hazardous materials, suggesting a partial decoupling of volume and toxicity that could reflect more responsible inputs or enhanced treatment.